Emerging Treatments for Subarachnoid Hemorrhage.

SAH Subarachnoid hemorrhage neurological patient. protocols treatments

Journal

CNS & neurological disorders drug targets
ISSN: 1996-3181
Titre abrégé: CNS Neurol Disord Drug Targets
Pays: United Arab Emirates
ID NLM: 101269155

Informations de publication

Date de publication:
22 Feb 2024
Historique:
received: 23 10 2023
revised: 19 12 2023
accepted: 01 01 2024
medline: 27 2 2024
pubmed: 27 2 2024
entrez: 27 2 2024
Statut: aheadofprint

Résumé

The current landscape of therapeutic strategies for subarachnoid hemorrhage (SAH), a significant adverse neurological event commonly resulting from the rupture of intracranial aneurysms, is rapidly evolving. Through an in-depth exploration of the natural history of SAH, historical treatment approaches, and emerging management modalities, the present work aims to provide a broad overview of the shifting paradigms in SAH care. By synthesizing the historical management protocols with contemporary therapeutic advancements, patient-specific treatment plans can be individualized and optimized to deliver outstanding care for the best possible SAH-related outcomes.

Identifiants

pubmed: 38409689
pii: CNSNDDT-EPUB-138718
doi: 10.2174/0118715273279212240130065713
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Matthew C Findlay (MC)

Department of Neurosurgery, School of Medicine, University of Utah, Salt Lake City, Utah, USA.

Mrinmoy Kundu (M)

Institute of Medical Sciences and SUM Hospital, Bhubaneswar, India.

Jayson R Nelson (JR)

Department of Neurosurgery, School of Medicine, University of Utah, Salt Lake City, Utah, USA.

Kyril L Cole (KL)

Department of Neurosurgery, School of Medicine, University of Utah, Salt Lake City, Utah, USA.

Candace Winterton (C)

Department of Neurosurgery, School of Medicine, University of Utah, Salt Lake City, Utah, USA.

Samuel Tenhoeve (S)

Department of Neurosurgery, School of Medicine, University of Utah, Salt Lake City, Utah, USA.

Brandon Lucke-Wold (B)

Department of Neurosurgery, University of Florida, Gainesville, Florida, USA.

Classifications MeSH